SCHEMBL7859249

SCHEMBL7859249

CC[C@H]1CCc2c(ncnc2N2CCOc3ccc(-c4cnc5nc(NC(=O)OC)[nH]c5c4)cc3C2)C1

nearest known ligand 0.33

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 6/20 0.33
TBK1 Q9UHD2 1/20 0.33
KIT P10721 1/20 0.32
S1PR1 P21453 2/20 0.32
AURKA O14965 1/20 0.31
AURKB Q96GD4 1/20 0.31
S1PR3 Q99500 1/20 0.31
ROCK2 O75116 1/20 0.31
CDC42BPA Q5VT25 1/20 0.31
CREBBP Q92793 1/20 0.31
TNIK Q9UKE5 1/20 0.31
PIK3C3 Q8NEB9 1/20 0.31
IDH1 O75874 1/20 0.31
ATR Q13535 1/20 0.31
ATRIP Q8WXE1 1/20 0.31
KDM4E B2RXH2 1/20 0.30
TSHR P16473 1/20 0.30
HTT P42858 1/20 0.30
GPR142 Q7Z601 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3717364 0.94 PIK3CA (0.34) PIK3CATBK1KITS1PR1AURKA
SCHEMBL13057045 0.92 PIK3CA (0.33) PIK3CATBK1S1PR1CREBBPTSHR
SCHEMBL858635 0.87 PIK3CA (0.35) PIK3CAKITKDM4ETSHRHTT
SCHEMBL3767906 0.86 KDM4E (0.34) PIK3CAKITKDM4ETSHRHTT
SCHEMBL3723449 0.86 PIK3CA (0.34) PIK3CATBK1CREBBPGPR142
SCHEMBL856798 0.85 PIK3CA (0.34) PIK3CATBK1KITKDM4ETSHR
SCHEMBL8594756 0.84 PIK3CA (0.35) PIK3CACREBBPPIK3C3GPR142
SCHEMBL3768247 0.84 KDM4E (0.32) PIK3CAKITKDM4ETSHRHTT
SCHEMBL3762761 0.84 KDM4E (0.32) PIK3CAKITKDM4ETSHRHTT
SCHEMBL861157 0.83 PIK3CA (0.34) PIK3CAKITCREBBPTNIKKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140080810-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture EXELIXIS, INC. (US) 2014-03-20 US disclosed
US-20140080810-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture EXELIXIS, INC. (US) 2014-03-20 US disclosed
US-8648066-B2 Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture EXELIXIS, INC. (US) 2014-02-11 US disclosed
US-8648066-B2 Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture EXELIXIS, INC. (US) 2014-02-11 US disclosed
US-20100298290-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture EXELIXIS, INC. (US) 2010-11-25 US disclosed
US-20100298290-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture EXELIXIS, INC. (US) 2010-11-25 US disclosed
WO-2010135524-A1 BENZOXAZEPINES BASED P13K/MT0R INHIBITORS AGAINST PROLIFERATIVE DISEASES EXELIXIS, INC. (US) 2010-11-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298290-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture MTOR, RICTOR, PIK3CA PIK3CA 3/4885TBK1 640/4885KIT 224/4885
US-20140080810-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture MTOR, RICTOR, PIK3CA PIK3CA 3/4885TBK1 628/4885KIT 190/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.